Analysis of bioMARKer Distribution and Individual Reproducibility Under Rivaroxaban Treatment in Japanese Patients with Non-Valvular Atrial Fibrillation (R-MARK Study, CVI ARO2)

International Heart Journal
Naomi HirotaTakeshi Yamashita

Abstract

The "on-therapy range" of direct oral anticoagulants is the 90% interval of drug concentration. Previously, we reported the on-therapy range of rivaroxaban in a single-center cohort. The present study aimed to confirm the range and intraindividual reproducibility in a multicenter cohort.Eligible patients with non-valvular atrial fibrillation under rivaroxaban treatment for prevention of ischemic stroke were enrolled from nine institutes in Tokyo, Japan, between June 2016 and May 2017 (n = 324). The first and second (three months later) blood samples both taken within 1-5 hours after rivaroxaban intake were analyzed (n = 219). Plasma concentration of rivaroxaban (PC-Riv) and prothrombin time (PT) with five reagents were measured.The 90% interval of PC-Riv was 47.3-532.9 ng/mL. The 90% interval of PT measured with RecombiPlasTin 2G was 11.8-22.3 seconds, the widest range among the five reagents examined. PC-Riv reproducibility within a 90% interval was evaluated bidirectionally (first-to-second and second-to-first), and 92.4% of samples were reproducible. The change rate (CR) of PC-Riv between two samplings ranged widely, and high CR (≥54.3%, cutoff for predicting non-reproducibility) was predicted by concomitant drugs (non-dihyd...Continue Reading

References

Aug 5, 2008·Journal of Chromatography. B, Analytical Technologies in the Biomedical and Life Sciences·G Rohde
Apr 26, 2011·The Journal of Pharmacology and Experimental Therapeutics·Mark Jean GnothSteffen Sandmann
Jun 6, 2012·Circulation Journal : Official Journal of the Japanese Circulation Society·Masatsugu HoriUNKNOWN J-ROCKET AF study investigators
Jan 12, 2013·British Journal of Clinical Pharmacology·Wolfgang MueckMichael Becka
Apr 9, 2013·Journal of the American College of Cardiology·Jeffrey D WesslerRobert P Giugliano
Sep 4, 2013·Clinical Pharmacokinetics·Wolfgang MueckMichael Becka
Sep 13, 2014·Journal of the American College of Cardiology·Adam CukerDavid A Garcia
Jan 17, 2015·Circulation. Cardiovascular Interventions·Andrew WangTed Feldman
Jun 25, 2017·The American Journal of Cardiology·Jeffrey B WashamUNKNOWN ROCKET AF Steering Committee and Investigators
Apr 11, 2018·Arrhythmia & Electrophysiology Review·Pascal VranckxHein Heidbuchel
Oct 30, 2018·International Heart Journal·Yasuo OkumuraUNKNOWN SAKURA AF Registry Investigators

❮ Previous
Next ❯

Citations


❮ Previous
Next ❯

Related Concepts

Related Feeds

Atrial Filbrillation

Atrial fibrillation refers to the abnormal heart rhythm characterized by rapid and irregular beating of the atria. Here is the latest research.

Arrhythmia

Arrhythmias are abnormalities in heart rhythms, which can be either too fast or too slow. They can result from abnormalities of the initiation of an impulse or impulse conduction or a combination of both. Here is the latest research on arrhythmias.

Atrial Fibrillation

Atrial fibrillation is a common arrhythmia that is associated with substantial morbidity and mortality, particularly due to stroke and thromboembolism. Here is the latest research.